This was all announced several months ago. However, our big hope, ongoing, is the results of our application to the FDA regarding the Hepa-fat scan. If we get vthis it will boost our market significantly.
Regarding the AR, the increase year on year on sales was very good, over 30%. I am not an accountant but it looks to me like we are very close to break even provided we can maintain out last quarter results. I regard the stock as a 'hold' at worst and perhaps even an 'accumulate' on the hope that the Hepa-fat scan gets the green light. If and when it does get approval, it would be a definite buy.
Al my uneducated opinion, of course.
20% drop in price today, wednesday, page-5
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.68M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29809 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.12pm 29/07/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable